Karim Rihawi

Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?

Angela Dalia Ricci, Alessandro Rizzo, Fabiola Lorena Rojas Llimpe et al. · Cancers · 2021 · 97 citations · Full text

Medicine, Oncology, Pharmacology +15

Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management

Khurum Khan, Mabel Wong, Karim Rihawi et al. · The Oncologist · 2016 · 66 citations · Full text

Medicine, Oncology, Pharmacology +14

Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines?

Marta Bonotto, Lorenzo Gerratana, Donatella Iacono et al. · The Oncologist · 2015 · 56 citations · Full text

Medicine, Oncology, Breast Oncology +6

MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report

Karim Rihawi, Roberta Alfieri, Michelangelo Fiorentino et al. · Translational Oncology · 2018 · 45 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

Johann S. de Bono, Chia‐Chi Lin, Li‐Tzong Chen et al. · British Journal of Cancer · 2020 · 42 citations · Full text

Medicine, Oncology, Pharmacology +13